Medline (MDLN) Inventory (2024 - 2026)

Medline (MDLN) has 3 years of Inventory data on file, last reported at $4.8 billion in Q1 2026.

• Quarterly Inventory changed N/A year-over-year to $4.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 billion (changed N/A YoY) and the FY2025 annual result came in at $4.8 billion, up 7.02% from the prior year.
• Inventory climbed to $4.8 billion in Q1 2026 per MDLN's latest filing, from $4.8 billion in the prior quarter.
• Across five years, Inventory topped out at $4.8 billion in Q1 2026 and bottomed at $4.5 billion in Q4 2024.
• The 3-year median for Inventory is $4.8 billion (2025), against an average of $4.7 billion.
• Peak annual rise in Inventory reached 7.02% in 2025, while the deepest fall reached 7.02% in 2025.
• Tracing MDLN's Inventory over 3 years: stood at $4.5 billion in 2024, then grew by 7.02% to $4.8 billion in 2025, then rose by 0.8% to $4.8 billion in 2026.
• Per Business Quant, the three latest MDLN Inventory figures stand at $4.8 billion (Q1 2026), $4.8 billion (Q4 2025), and $4.5 billion (Q4 2024).

Peer Comparison